Q2 2022 Holdings
Filed 2022-07-29 | 177 holdings | $285.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $86.8M | 566,842 | 30.4% |
| Boston Scientific Corp.(BSX) | Common | 101137107 | $29.6M | 795,215 | 10.4% |
| Biogen Inc.(BIIB) | Common | 09062X103 | $27.7M | 135,639 | 9.7% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $18.7M | 128,414 | 6.6% |
| argenx SE(ARGX) | Sponsored ADR | 04016X101 | $14.6M | 38,456 | 5.1% |
| BioNTech SE(BNTX) | Sponsored ADS | 09075V102 | $14.2M | 95,042 | 5.0% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $10.6M | 128,004 | 3.7% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $10.2M | 47,894 | 3.6% |
| BeiGene, Ltd.(ONC) | Sponsored ADR | 07725L102 | $8.3M | 51,018 | 2.9% |
| Addus HomeCare Corp.(ADUS) | Common | 006739106 | $7.0M | 83,632 | 2.4% |
| AMN Healthcare Services, Inc.(AMN) | Common | 001744101 | $6.7M | 61,201 | 2.4% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $6.3M | 67,794 | 2.2% |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | Common | 04280A100 | $5.5M | 156,875 | 1.9% |
| Acadia Healthcare Company, Inc.(ACHC) | Common | 00404A109 | $4.9M | 72,307 | 1.7% |
| Cytokinetics, Inc.(CYTK) | Common | 23282W605 | $4.7M | 119,898 | 1.7% |
| Align Technology, Inc.(ALGN) | Common | 016255101 | $4.5M | 18,894 | 1.6% |
| Caribou Biosciences, Inc.(CRBU) | Common | 142038108 | $3.8M | 699,377 | 1.3% |
| Arvinas, Inc.(ARVN) | Common | 04335A105 | $3.6M | 85,997 | 1.3% |
| Arcutis Biotherapeutics, Inc.(ARQT) | Common | 03969K108 | $3.2M | 148,874 | 1.1% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | Common | 09058V103 | $2.9M | 277,434 | 1.0% |
| Adaptive Biotechnologies Corp.(ADPT) | Common | 00650F109 | $2.7M | 337,722 | 1.0% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $1.6M | 162,599 | 0.6% |
| Cogent Biosciences, Inc.(COGT) | Common | 19240Q201 | $1.3M | 146,911 | 0.5% |
| Acadia Pharmaceuticals Inc.(ACAD) | Common | 004225108 | $1.0M | 72,225 | 0.4% |
| Beam Therapeutics Inc.(BEAM) | Common | 07373V105 | $612.0K | 15,817 | 0.2% |
| ALX Oncology Holdings Inc.(ALXO) | Common | 00166B105 | $536.0K | 66,211 | 0.2% |
| Bicycle Therapeutics PLC(BCYC) | Sponsored ADS | 088786108 | $337.0K | 20,065 | 0.1% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $331.0K | 88,335 | 0.1% |
| Black Diamond Therapeutics, Inc.(BDTX) | Common | 09203E105 | $325.0K | 131,990 | 0.1% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $318.0K | 539,408 | 0.1% |
| Unitedhealth Group Inc.(UNH) | Common | 91324P102 | $164.1K | 319,510 | 0.1% |
| Amgen Inc.(AMGN) | Common | 031162100 | $133.4K | 548,418 | 0.0% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $102.0K | 1,650,765 | 0.0% |
| Vertex Pharmaceuticals Inc.(VRTX) | Common | 92532F100 | $101.8K | 361,231 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $91.7K | 516,652 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $84.5K | 142,864 | 0.0% |
| AstraZeneca PLC(AZN) | Sponsored ADR | 046353108 | $74.3K | 1,124,741 | 0.0% |
| Horizon Therapeutics plc | Shares | G46188101 | $69.9K | 876,089 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $68.2K | 627,292 | 0.0% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $60.3K | 782,735 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $59.4K | 1,132,103 | 0.0% |
| Eli Lilly and Company(LLY) | Common | 532457108 | $57.2K | 176,432 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $53.0K | 97,605 | 0.0% |
| McKesson Corp.(MCK) | Common | 58155Q103 | $52.4K | 160,722 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $50.3K | 552,122 | 0.0% |
| Moderna, Inc.(MRNA) | Common | 60770K107 | $46.9K | 328,524 | 0.0% |
| Cigna Corp.(CI) | Common | 125523100 | $45.6K | 173,106 | 0.0% |
| Stryker Corp.(SYK) | Common | 863667101 | $44.9K | 225,678 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $36.1K | 196,047 | 0.0% |
| Seagen Inc.(SGENUSD) | Common | 81181C104 | $34.5K | 195,183 | 0.0% |